Patient adherence in COPD

Cited by (489)

Items 301–400 of 489

1. Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy
   Lindsay G.S. Bengtson, Michael R. DePietro, Jeffrey McPheeters, Kathleen M. Fox · 2018 · Therapeutic Advances in Respiratory Disease
2. Is it preferable to administer a bronchodilator once- or twice-daily when treating COPD?
   Maria Gabriella Matera, Barbara Rinaldi, Concetta Ambrosio, Mario Cazzola · 2023 · Respiratory Medicine
3. Inhaler Operability and Patient Satisfaction Regarding Genuair® and Respimat® Inhalers for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Study
   Hiroyuki Ohbayashi, Sahori Kudo, Masatake Ishikawa · 2017 · Pulmonary Therapy
4. A qualitative study of clinician perceptions regarding the potential role for digital health interventions for the management of COPD
   Patrick Slevin, Threase Kessie, John Cullen, Marcus W. Butler, Seamas C. Donnelly, Brian Caulfield · 2021 · Health Informatics Journal
5. Micro-phenomenological approach to explore the patient experience during an initial spirometry examination to diagnose COPD in general practice in France
   Matthieu Bremond, Anthony Berthelot, Laurent Plantier, Hervé Breton, Maxime Pautrat · 2021 · BMJ Open
6. Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD
   Mario Cazzola, Josuel Ora, Alessanda Di Paolo, Ermanno Puxeddu, Luigino Calzetta, Paola Rogliani · 2016 · Pulmonary Pharmacology & Therapeutics
7. Concomitant pulmonologist and primary care for chronic obstructive pulmonary disease: a population study
   Andrea S. Gershon, Erin M. Macdonald, Jin Luo, Peter C. Austin, Samir Gupta, Khalil Sivjee, Ross E. G. Upshur, Shawn David Aaron · 2017 · Family Practice
8. Behavioural modes of adherence to inspiratory muscle training in people with chronic obstructive pulmonary disease: a grounded theory study
   Dorthe Sørensen, Marie Ernst Christensen · 2018 · Disability and Rehabilitation
9. Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy
   Jacyntha A. Sterling · 2007 · Hospital Pharmacy
10. Credentialed pharmacist-led home medicines reviews targeting treatable traits and their impact on health outcomes in people with chronic obstructive pulmonary disease: a pre- and post-intervention study
    Muhammad Rehan Sarwar, Vanessa M. McDonald, Michael John Abramson, Sally Wilson, Anne Elizabeth Holland, Billie Bonevski, Ajay Singh Mahal, Eldho Mathew Paul, Brian Meier, Johnson George · 2024 · International Journal of Clinical Pharmacy
11. Shared decision making and inhaled medication adherence in patients with COPD, asthma and cystic fibrosis: a systematic review
    Maria Achterbosch, Carina M.E. Hansen, Paul L.P. Brand, Liset van Dijk, Job F. M. van Boven · 2025 · Respiratory Medicine
12. Objective Assessment of Adherence to Inhalers by COPD Patients
    Sulaiman, Imran, Cushen, Breda, Greene, Garrett, Seheult, Jansen, Seow, Dexter, Rawat, Fiona, MacHale, Elaine, Mokoka, Matshediso, Moran, Catherine Nora, Bhreathnach, Aoife Sartini et al. · 2019 · Case Medical Research
13. A Review of Sensor-Based Interventions for Supporting Patient Adherence to Inhalation Therapy
    Jing Ma, Xu Sun, Bingjian Liu · 2024 · Patient Preference and Adherence
14. Adherence to Inhaled Therapy in Patients with COPD Associated to Pneumoconiosis
    Yating Peng, Jia‐Xi Duan, Xin Li, Yuqin Zeng, Zijing Zhou, Minghua Deng, Ruoyun Ouyang, Yan Chen, Shan Cai, Ping Chen · 2021 · International Journal of COPD
15. Ligand–Receptor Binding Kinetics in Drug Design
    D. V. Borisov, Alexander V. Veselovsky · 2020 · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry
16. Public involvement in chronic respiratory diseases research: A qualitative study of patients', carers' and citizens' perspectives
    Margarida Areia, Liliana Dias, Paula Matos, Daniela Maria Pias de Figueiredo, Ana Luísa Neves, Emília Costa, Cláudia Chaves Loureiro, José Laerte Boechat, António Baía Reis, Pedro Simões et al. · 2023 · Health Expectations
17. Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease
    Andrew M. Wilson, Claire Brockwell, Sundari Ampikaipakan, Darren W. Sexton, David Price, Daryl Freeman, Mike D. Thomas, Muzammil Ali · 2014 · International Journal of COPD
18. An overview of assessment and management in COPD
    Margaret Barnett · 2009 · British Journal of Community Nursing
19. External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort)
    On behalf of the PROEPOC/COPD study group, Maite Espantoso-Romero, Miguel Román-Rodríguez, Ana Duarte-Pérez, Jaime Gonzálvez Rey, Pedro A. Callejas-Cabanillas, Đurđica Kašuba Lazić, Berta Anta-Agudo, Pere Torán‐Monserrat, Rosa Mª Magallón-Botaya et al. · 2016 · BMC Pulmonary Medicine
20. Modeling and Analysis of Postdischarge Intervention Process to Reduce COPD Readmissions
    Sujee Lee, Sijie Wang, Philip A. Bain, Tammy Kundinger, Craig Sommers, Christine Baker, Jingshan Li · 2018 · IEEE Transactions on Automation Science and Engineering
21. Development of a Web-Based Tool Built From Pharmacy Claims Data to Assess Adherence to Respiratory Medications in Primary Care
    Alia Yousif, Sandra Peláez, Catherine Lemière, Amélie Forget, Catherine Dalal, Maria-Kim Turcotte, Marie-France Beauchesne, Lucie Blais · 2020 · Respiratory Care
22. THE THE EFFECT OF INDIVIDUAL PSYCHOEDUCATION INTERVENTION ON SELF EFFICACY AMONG OPIOID DEPENDENT PATIENTS IN METHADONE CLINICS
    Engku Mardiah Engku Kamarudin, Wan Shahrazad Wan Sulaiman, Norulhuda Sarnon, Aizan Sofia Amin · 2020 · Journal of Nusantara Studies (JONUS)
23. Evaluation of the association of adherence to long-term home oxygen therapy and clinical markers and five-year mortality in patients with Chronic obstructive pulmonary disease
    Vitória Klein Marcondes, Thais Sayuri Kuwazuru, Luiz Paulo Corrêa e Silva, Talita Jacon Cezare, Estefania Aparecida Thome Franco, Robson Prudente, Suzana Érico Tanni · 2020 · Jornal Brasileiro de Pneumologia
24. Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences
    Shaonan Liu, Jiaqi Lai, Lei Wu, Xinfeng Guo · 2021 · Patient Preference and Adherence
25. Once daily Long-acting beta 2 -agonists/Inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease
    Agnieszka Śliwka, Miłosz Jankowski, Iwona Gross‐Sondej, Roman Nowobilski, Małgorzata Maria Bała · 2016 · Cochrane Database of Systematic Reviews
26. Patient preference for a maintenance inhaler in chronic obstructive pulmonary disease: a comparison of Breezhaler and Respimat
    Philip O’Hagan, Juergen Dederichs, Boomi Viswanad, Μatthias Gasser, Susann Walda · 2018 · Journal of Thoracic Disease
27. Comparison of the efficacy and safety of arformoterol 15 μg twice daily and arformoterol 30 μg once daily in COPD: A single-dose, multicenter, randomized, modified-blind, two-way crossover study
    Reynold A. Panettieri, Neil R. MacIntyre, Michael W. Sims, Edward Kerwin, Charles M. Fogarty, Michael James Noonan, Raymond Claus, William T. Andrews · 2009 · Clinical Therapeutics
28. Clustering of Unhealthy Lifestyle Behaviors is Associated with a Low Adherence to Recommended Preventive Practices Among COPD Patients in Spain
    Javier de Miguel‐Díez, Rodrigo Jiménez‐García, Valentín Hernández‐Barrera, Luís Puente‐Maestu, Irene Jarana Aparicio, Alicia Oliva Ramos, Ana López‐de‐Andrés, Pilar Carrasco‐Garrido · 2014 · COPD Journal of Chronic Obstructive Pulmonary Disease
29. Indacaterol: pharmacologic profile, efficacy and safety in the treatment of adults with COPD
    Christopher K. M. Hui, Kian Fan Chung · 2011 · Expert Review of Respiratory Medicine
30. Biologics for eosinophilic COPD: current applications and future prospects
    Qi Qi, Wenbei Peng, Bohan Yang, Shijie Liu, Ying Pu, Qiong Zhou · 2026 · Frontiers in Immunology
31. The impact of community pharmacy-led medicines management support for people with COPD
    Sarah Alton, Lisa J Farndon · 2018 · British Journal of Community Nursing
32. Real-World Use of Inhaled COPD Medications: the Good, the Bad, the Ugly
    Valerie G. Press · 2024 · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
33. Application of e-Health tools in the assessment of inhalation therapy adherence in patients with chronic obstructive pulmonary disease: Scoping review coupled with bibliometric analysis
    Haibo Xu, Xiaoke Jiang, Qiuxuan Zeng, Ronghua Li · 2024 · Respiratory Medicine
34. T iotropium as part of inhaled polytherapy: Adherence and associated health‐care utilization
    Tzahit Simon‐Tuval, Nimrod Maimon · 2014 · Respirology
35. The use of COPD maintenance therapy following spirometry in General Practice
    Vibeke Gottlieb, Anne Marie Lyngsø, Ditte Sæbye, Anne Frølich, Vibeke Backer · 2016 · European Clinical Respiratory Journal
36. Adherence to an online exercise program for COPD patients in the home environment- a pilot study
    Marit Dekker-van Weering, Miriam M. R. Vollenbroek-Hutten, Hermie J Hermens · 2016 · Health and Technology
37. Emergency room visits for chronic obstructive pulmonary disease in Illinois counties: An epidemiological study based on the Social Ecological Model
    Justin Tyler McDaniel · 2018 · Chronic Illness
38. “Breathing New Life Into Chronic Obstructive Pulmonary Disease (COPD)” – Results From An Online Survey Of UK Patients
    Steve Titmarsh, Michele Poliziani, Richard E. K. Russell · 2019 · International Journal of COPD
39. Communication of Pulmonary Function Test Results: A Survey of Patient’s Preferences
    D. Zagami, J. Hockenhull, Alan Bodger, K. Sriram · 2015 · PLoS ONE
40. Can ENDS technology facilitate the delivery of medicines?
    Federico Buonocore, Stephen Barton, Shereen Nabhani‐Gebara, G. Calabrese · 2023 · Journal of Drug Delivery Science and Technology
41. Adherence to Therapy in Chronic Obstructive Pulmonary Disease
    Tamás Ágh, Ágnes Mészáros · 2012 · InTech eBooks
42. Medication adherence in chronic obstructive pulmonary disease
    Debbie Duncan · 2015 · Practice Nursing
43. COPD-treating nurses’ preferences for inhaler attributes – a discrete choice experiment
    Mette Bøgelund, Lise Meinicke Hagelund, Mikael Bergholdt Asmussen · 2016 · Current Medical Research and Opinion
44. Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution
    Fulvio Braido, Angelo Guido Corsico, Davide Paleari, Alessio Piraino, Luca Cavalieri, Nicola Scichilone · 2022 · Therapeutic Advances in Respiratory Disease
45. Bronchodilator efficacy of tiotropium/formoterol (18/12 µg once daily via a Discair inhaler), tiotropium alone (18 µg by Handihaler) or combined with formoterol (12 µg twice daily by Aerolizer) in adults with moderate-to-severe stable COPD
    Pınar Yildiz, Mesut Bayraktaroğlu, Hakan Günen · 2019 · Current Medical Research and Opinion
46. Misuse of Respiratory Inhalers Among Hospitalized Patients in a Tertiary Health Care Hospital in Kabul
    Ershad Ahmad Mushkani, Fahima Hamidy, Tawfiq Ahmad, Mohammad Asef Adelyar · 2023 · International Journal of COPD
47. Sociodemographic inequities in unscheduled asthma care visits among public assistance recipients in Japan: additional risk by household composition among workers
    Daisuke Nishioka, Junko Saito, Keiko Ueno, Naoki Kondo · 2023 · BMC Health Services Research
48. Perspectives on Treatment Decisions, Preferences, and Adherence and Long-Term Management in Asthma and COPD: A Qualitative Analysis of Patient, Caregiver, and Healthcare Provider Insights
    Miguel Román-Rodríguez, Ilona McMullan, Michelle Warner, Chris H. Compton, Ruth Tal‐Singer, Jean M Orlow, MeiLan King Han · 2024 · Patient Preference and Adherence
49. Use and Discontinuation Rates of Long‐Acting Injectable Antipsychotics Between Race/Ethnicity in Older Adults Using Medicaid Databases
    Christopher M. Cassara, Jianing Xu, Daniel B. Hall, Xianyan Chen, Henry Nolan Young, Joshua Caballero · 2025 · Journal of the American Geriatrics Society
50. Technological and digital innovations in improving adherence to asthma medication therapy
    Petar Nikolov, Guenka Ivanova Petrova · 2025 · Pharmacia
51. Severe COPD Exacerbation Risk and Long-Acting Bronchodilator Treatments: Comparison of Three Observational Data Analysis Methods
    Melissa H. Roberts, Douglas W. Mapel, Matthew E. Borrego, Dennis W. Raisch, L.L. Georgopoulos, David N. van der Goes · 2015 · Drugs - Real World Outcomes
52. Open innovation challenge as a strategy for developing new mobile health solutions
    Ovidio J. González de Uña, Francisco Javier López Narbona, Javier Ferrero Álvarez-Rentería, Alejandro Carballar · 2018 · Medicina Clínica (English Edition)
53. Treatment of stable chronic obstructive pulmonary disease: protocol for a systematic review and evidence map
    Claudia Caroline Dobler, Magdoleen H. Farah, Allison S. Morrow, Mouaz Alsawas, Raed Benkhadra, Bashar Hasan, Larry J. Prokop, Zhen Wang, Mohammad Hassan Murad · 2019 · BMJ Open
54. Current pharmacological strategies for symptomatic reduction of persistent breathlessness – a literature review
    Diana H. Ferreira, Slavica Kochovska, Richard McNeill, David C. Currow · 2022 · Expert Opinion on Pharmacotherapy
55. GFF MDI for the improvement of lung function in COPD – A look at the PINNACLE-1 and PINNACLE-2 data and beyond
    Klaus Friedrich Rabe · 2017 · Expert Review of Clinical Pharmacology
56. ELLIPTA Versus DISKUS plus HandiHaler in COPD: A Randomized, Open-Label, Crossover Study in a Clinical Trial Setting
    Edward Kerwin, Selwyn Spangenthal, Michael T. Zvarich, Valerie Millar, Renu G. Jain, Kathryn A. Collison, Raj Kumar Sharma · 2020 · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
57. Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD
    Gaetano Caramori, Ian Michael Adcock, Kian Fan Chung · 2014 · International Journal of COPD
58. Aspectos psicológicos de la rehabilitación pulmonar en el paciente con enfermedad pulmonar obstructiva crónica
    Paula Beatriz Repetto, MARGARITA BERNALES S, Matías González T · 2011 · Revista chilena de enfermedades respiratorias
59. Experiences and perceptions of the short-form Sun-style Tai Chi training in Caucasians with COPD
    Regina Wai Man Leung, Zoe Jane McKeough, Matthew J. Peters, Jennifer Ailsey Alison · 2014 · European Journal of Integrative Medicine
60. Frailty in older patients with chronic obstructive pulmonary disease (COPD) undergoing a multidisciplinary rehabilitation
    Martina Vigorè, Nicolò Granata, Raffaella Vaninetti, Roberta Borri, Roberto Maestri, Simona Conti, Giancarlo Piaggi, Gioele Cremonese, G Callegari, Antonia Pierobon · 2024 · Minerva Respiratory Medicine
61. Effects of a 10-week pulmonary rehabilitation program based on the 5A nursing model in patients with interstitial lung disease: a quasi-experimental study
    Meihua Li, Yuyang Chang, Jia Fan, Bing Liang, Danhua Qu · 2025 · BMC Nursing
62. Importancia y variabilidad de los síntomas en la EPOC. Su importancia para el tratamiento
    José Luís López-Campos · 2010 · Archivos de Bronconeumología
63. ¿Es útil la implantación de programas de gestión clínica de los pacientes con enfermedad pulmonar obstructiva crónica? Comparación de la efectividad de dos intervenciones sobre la evolución clínica y la atención recibida
    Ingrid Solanes, Ignasi Bolíbar, Maria Antònia Pou, Meritxell Peiró, Pepi Valverde, Mar Fraga, Casimira Medrano, Teresa Bigorra, Montserrat Freixas, Iskra Ligüerre Casals et al. · 2017 · Atención Primaria
64. Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator
    Eulalia Jiménez, Carol Astbury, Muna Albayaty, Ulrika Wählby Hamrén, Beatriz Seoane, Cristina Villarroel, Helena Pujol, Maria Jesus Bermejo, Ajay Aggarwal, Ioannis Psallidas · 2020 · Respiratory Research
65. Real-life asthma strategies: the missing piece in the jigsaw
    David Brendan Price, Leif Hilding Bjermer, John Haughney, Nicolás Roche, Jean J. Bousquet, Elizabeth V. Hillyer, Alison Chisholm · 2012
66. Distant Compliance with Treatment in Patients with Chronic Respiratory Diseases: Asthma, Copd and Asthma-Copd Overlap Syndrome. Prospective Study
    Simona Maria Ţîrcă, Marius Sorin Ciontea, Elena Vlad, Florin Dumitru Mihaltan · 2021 · Internal Medicine
67. Understanding perspectives and choices for sedentary behaviour and physical activity in older adults’ post-acute exacerbation of chronic obstructive pulmonary disease
    Chevonne Chang, John Wong, Ahmad Iqbal Kamari, Sophia Chen Hui Cheah, Mark Anthony Wen Kein Chan, Rahizan Zainuldin · 2021 · Proceedings of Singapore Healthcare
68. Concordance between reported medication taking behavior and prescription instructions for patients with chronic obstructive pulmonary disease visiting community pharmacies
    Theresa R. Prosser, Suzanne G. Bollmeier · 2022 · Journal of the American Pharmacists Association
69. Ethical Dilemmas in Physicians’ Consultations with COPD Patients
    Jónína Sigurgeirsdóttir, Sigríður Halldórsdóttir, Ragnheiður Harpa Arnardóttir, Gunnar Guðmundsson, Eythor Hreinn Bjornsson · 2022 · International Journal of COPD
70. Qualitative and quantitative evaluation of a standardized training model for improving patients' ability to use inhalers
    Yu-Wen Huang, Fangzhou Miao, Yunjian Dai, Cuie Chang, Xiaoyu Zhang, Haibin Dai · 2023 · Frontiers in Public Health
71. A comprehensive evaluation of online inhaler use techniques for obstructive airway disease
    Brandon Luu, Anu Chinnadurai, Omer Ahmad Choudhary, Nikki Breede, Lee M. Fidler, Clodagh M. Ryan, Mohammad Hashim Khan, Ambrose K. Lau, Alina J. Blazer, Kirsten Wentlandt et al. · 2024 · Respiratory Medicine
72. Towards successful self-management and empowerment for COPD patients
    Beatrix Zechmann, Jan Bobeth, Manfred Tscheligi · 2016 · International Conference on Human-Computer Interaction with Mobile Devices and Services Adjunct (MobileHCI Adjunct)
73. Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy
    Chitra Lal, Charlie Strange · 2016 · International Journal of COPD
74. Code-Switching in Selling and Buying at Segiri Market Samarinda, East Kalimantan: a Sociolinguistics Study
    Islamiah Bastiar, Sri Marmanto, Sumarlam Sumarlam · 2018 · Lingua Cultura
75. Assessment of a Domiciliary Integrated Pulmonary Rehabilitation Program for Patients with a History of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective 12-Month Observational Study
    Yi Li, Jing Feng, Yue-Chuan Li, Wei Jia, Hongyu Qian · 2018 · Medical Science Monitor
76. The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study
    Gema Requena, Daniel Dedman, Jennifer Kathleen Quint, Rebecca Elisabeth Ghosh, Rachael Williams, Jeanne Marie Pimenta · 2021 · International Journal of COPD
77. The impact of community pharmacy-led medicines management support for people with COPD
    Sarah Alton, Lisa J Farndon · 2018 · British Journal of Community Nursing
78. Incentive-driven post-discharge compliance management for chronic disease patients in healthcare service operations
    Aditya Mahadev Prakash, Qiao‐Chu He, Xiang Zhong · 2019 · IISE Transactions on Healthcare Systems Engineering
79. Effects of loaded deep breathing training combined with PERMA model in lung cancer patients undergoing surgery: a randomized controlled trial
    Ziyu Wang, Lin Juan Yu, Chun-yu Song, Hui‐Ping Cao, Zhuo Yang, Shuai Qiao, Xiaoyu Li, Jiao Xie · 2025 · Supportive Care in Cancer
80. Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease
    Kesavan Suresh Babu, Jaymin Bhagwanji Morjaria · 2015 · Therapeutic Advances in Respiratory Disease
81. IMPACT OF COUNSELING ON COMPLIANCE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS ATTENDING GENERAL MEDICINE OUT PATIENT DEPARTMENT IN A TERTIARY CARE HOSPITAL: A PROSPECTIVE STUDY
    Manish Patel, Monila Patel, Wasimahmed Sachora, Vijay A. Ghodela, Patel Mb · 2013 · DOAJ (DOAJ: Directory of Open Access Journals)
82. Wie praxisrelevant sind die GOLD-Empfehlungen für den ambulanten Alltag bei COPD?
    Björn Laudahn, Sören Schmidtmann · 2015 · Pneumo News
83. Bronchodilator efficacy of 18 µg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial
    Pınar Yildiz, Mesut Bayraktaroğlu, Didem Görgün, Funda Seçik · 2016 · International Journal of COPD
84. Breath-actuated INhalation TheRapy: survey of phySicians’ PErCepTion (INTROSPECT) in Nepal
    Ramesh Chokhani, Vaibhav Gaur, Jaideep A. Gogtay · 2022 · Journal of Asthma
85. Monitoring and screening COPD in community pharmacies: experimentation in Italy
    Francesca Baratta, Irene Pignata, Roberta Onorati, Roberto Gnavi, Giuseppe Costa, Paola Brusa, Teresa Spadea · 2023 · Pharmacy Practice
86. Umeclidinium plus vilanterol versus fluticasone propionate plus salmeterol for chronic obstructive pulmonary disease: a meta-analysis of randomized, controlled trials
    Chunjuan Zhai, Fen Wang, Ruie Xu, Xia Sun, Wenbin Ma, Li Wang · 2024 · Postgraduate Medical Journal
87. Validation of the Onset of Effect Questionnaire in Participants With Chronic Obstructive Pulmonary Disease
    Charlie Strange, Barry J. Make, Frank J. Trudo, Gale Harding, Danielle N. Rodriguez, James M. Eudicone, Norbert Feigler, Hitesh N. Gandhi · 2024 · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
88. Understanding patient adherence to inhaled medication: The social representations of COPD
    A. Duarte-de-Araújo, Pedro Teixeira, Maria Manuel Figueiredo, Venceslau Pinto Hespanhol, J. Correia-de-Sousa · 2017 · Revista Portuguesa de Pneumologia
89. Primary prescription adherence for obstructive lung disease in a primary care population
    Alexander G. Singer, Alan Katz, Lisa LaBine, Lisa Marie Lix, Marina S. Yogendran, Ian P Sinha, Elissa Michele Abrams · 2021 · Allergy Asthma and Clinical Immunology
90. What happens after pulmonary rehabilitation?
    Carlos Augusto Camillo, Lissa Spencer · 2021 · European Respiratory Society eBooks
91. Primary Care Perspective on Chronic Obstructive Pulmonary Disease Management
    Barry J. Make, Mark H. Belfer · 2011 · Postgraduate Medicine
92. Indacaterol 75 µg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective
    E. Kerwin, James D. Williams · 2013 · Therapeutic Advances in Respiratory Disease
93. Medication adherence in chronic obstructive pulmonary disease
    Debbie Duncan · 2015 · Nurse Prescribing
94. Systemic Exposures of Fluticasone Propionate and Salmeterol Following Inhalation via Metered Dose Inhaler with the Mini Spacer Compared with the Aerochamber Plus Spacer
    Rashmi S. Mehta, Mickaël Montembault, Francis Warren, Ashutosh Gupta, Noushin Brealey, Alison C. Moore · 2016 · Journal of Aerosol Medicine and Pulmonary Drug Delivery
95. Reto de innovación abierta como estrategia para desarrollar nuevas soluciones de salud móvil
    Ovidio J. González de Uña, Francisco Javier López Narbona, Javier Ferrero Álvarez-Rentería, Alejandro Carballar · 2017 · Medicina Clínica
96. Chronic Obstructive Pulmonary Disease
    Stefanie Poehacker, Megha Garg, Claudia Drossel · 2018 · Springer eBooks
97. ‘Compliance in Chronic Obstructive Pulmonary Disease Patients Attending Pulmonary Medicine OPD in a Tertiary Care Hospital: Prospective study’
    Assistant professor. Dept. of Pharmacology, MMIMSR, Mullana, Ambala, Haryana, India, Anshu Gupta · 2013 · IOSR Journal of Dental and Medical Sciences
98. DEFRAGMENTING HEALTH CARE FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Claudia Caroline Dobler · 2016 · Australasian Medical Journal
99. IMPACT OF THE FORM OF MEDICATION ON TREATMENT ADHERENCE IN RESPIRATORY TUBERCULOSIS PATIENTS
    T. E. Tyulkova, Наталья Давыдовна Пирогова, Regional TB Dispensary, Tyumen, Russia, R. M. Bekova, Regional TB Dispensary, Tyumen, Russia · 2017 · Tuberculosis and lung diseases
100. Exploring perspectives on chronic obstructive pulmonary disease in people who smoke heroin: a qualitative study
     Rebecca Nightingale, Paul Griffiths, Kevin J. Mortimer, Paul Phillip Walker, Tara Byrne, Kerry Marwood, Sally Morrison–Griffiths, Sue Renwick, Jamie Rylance, Hassan Burhan · 2020 · BJGP Open